Biotech · Private company
AlgoTherapeutix
Track this companyFree. Adds AlgoTherapeutix to your Dealase workspace and tells you when its record changes.
Clinical trials21 recruiting or active
Pipeline programs3From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline3
- Amitriptyline HydrochloridePhase 2 · ErythromelalgiaClinicalTrials.gov · fetched Nov 12, 2026
- ATX01 10%Phase 2 · Chemotherapy-induced Peripheral NeuropathyClinicalTrials.gov · fetched Nov 12, 2026
- ATX01 15%Phase 2 · Chemotherapy-induced Peripheral NeuropathyClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials2
- EASE (Efficacy of ATX01 Study in Erythromelalgia)PHASE2 · COMPLETED · started Jun 14, 2023ClinicalTrials.gov NCT05917912 · fetched Nov 12, 2026
- Efficacy and Safety of ATX01 in Adult Patients With CIPN (Chemotherapy-induced Peripheral Neuropathy)PHASE2 · ACTIVE_NOT_RECRUITING · started Feb 28, 2023ClinicalTrials.gov NCT05593614 · fetched Nov 12, 2026